Novavax’s updated Covid-19 vaccine receives FDA emergency use authorisation
Pharmaceutical Business Review
SEPTEMBER 2, 2024
The Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) [NVX-CoV2705] is now authorised for active immunisation against Covid-19. Following the EUA, the vaccine is also recommended by the US Centers for Disease Control and Prevention (CDC). Our updated vaccine targets JN.1, 1.” “Our updated vaccine targets JN.1,
Let's personalize your content